arrow
I

Ioana R. Preston

Lahey Hospital and Medical Center
H指数:39
被引数:7,167

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sotatercept Safety and Efficacy in Intermediate–Low Risk Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR

sotatercept 在中低风险肺动脉高压中的安全性和有效性:PULSAR 和 STELLAR 的合并分析

Chest
IF8.6
2026-05-270
PRE
Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study

指南推荐的心脏超声检查方法在肺动脉高压中的应用效果:CIPHER研究分析

2026-02-170
OAAI
Authors’ Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension

作者关于国际心肺移植学会关于肺动脉高压风险分层共识声明的观点

2025-10-220
PRE
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension

国际心脏与肺移植学会(ISHLT)关于肺动脉高压风险分层共识声明

2025-09-050
PRE
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis

sotatercept 用于诊断后第一年的肺动脉高压

2025-09-012
PRE
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

中危肺动脉高压患者治疗的证据空白: 专家共识

2024-12-012
PRE
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
2023-09-1120
OAAI
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Sotatercept治疗肺动脉高压的3期试验

2023-04-20202
PRE
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension
2022-10-0413
OA